il2m INTERNATIONAL CORP.
OperatingBiotech · Burbank, CA
Financials
FY2011–FY2024 (no data for FY2015, FY2016, FY2017, FY2018) · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 2 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Cap table
Share counts as of Aug 31, 2014| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Stock | 186,963,310 | — | 100.0% | — |
Shares outstanding over timein today's share terms
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
1 personNames and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 20 filings on EDGAR- Form C-ARMar 12, 20250001903596-25-000116EDGAR
- Form C-ARMar 28, 20240001903596-24-000165EDGAR
- Form C-ARMar 29, 20230001903596-23-000227EDGAR
- Form C-AR/AMay 5, 20220001903596-22-000259EDGAR
- Form C-ARMay 3, 20220001903596-22-000241EDGAR
- Form CJan 14, 20220001520512-22-000001EDGAR
- Form 10-QApr 21, 20150001213900-15-002872EDGAR
- Form 10-QFeb 5, 20150001213900-15-000724EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.